Thu, Sep 18, 2014, 5:20 AM EDT - U.S. Markets open in 4 hrs 10 mins


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • jeremiahthirtythreeone jeremiahthirtythreeone Aug 7, 2013 6:28 PM Flag

    The huge potential of Belviq - the short term wall street antics will come to an end by necessity

    We must get a grasp of the huge potential of Belviq in both the treatment and prevention of two of the most serious and devastation diseases affecting people globally - obesity and T2DM.
    It is a rarity to have one medication with a unique mechanism of action that JUST HAPPENS to be effective against two diseases that are global epidemics and whose morbidity, mortality, and expense
    associated with them are staggering.

    One must be completely blind to understand this huge marketplace and what is amazing is that there is only one medication that can treat both!!!!

    Let me just mention T2DM and it'salarming facts:
    1. Prevalence of T2DM in the US is about 8% or about 25 million of the population
    2. More than 2 million cases are diagnosed in people older than 20
    3. As the dramatic increases in obesity continue, the prevalence of T2DM increases
    4. In Western society, people with T2DM are 3x more likely to be hospitalized than nondiabetic persons, it is the leading cause of blindness, accounts for more than 40% of new cases of end-stage renal
    disease, the risk of heart disease and stroke id 2-4x higher.
    5. Life expectancy is decreased by 10 years in T2DM patients
    6. the population of T2DM patients and associated costs will at least double in the next 25 years
    7. Presently at least 20% of health care expenditures are related to the treatment of people with diabetes.
    And I could go on...

    Do not be fooled by the short term antics of wall street - this too shall pass. The need is too great and there a is nothing out there with the duo effects of Belviq.

    There is a plenitude of hypoglycemic drugs out there but most are very expensive and inconvenient and with potential serious side effects. AND BELVIQ IS AS EFFECTIVE AND IN SOME CASES


    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.90-0.02(-0.51%)Sep 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.